Kenya’s TB/HIV funding request to the Global Fund zeros in on HIV prevention among key populations and on finding missing TB cases
Kenya was among the 35 countries that submitted funding requests to the Global Fund in Window 2 on 23 May 2017. Kenya’s TB/HIV funding request was for $421.9 million, made up of a $256.4 million allocation request, $138.9 million prioritized above-allocation request (PAAR) and a $26.6 million matching funds request. A $112.0 million malaria funding request was submitted on the same day ($60.1 million within allocation and $51.9 million PAAR).
On 23 May 2017, Zambia submitted both TB/HIV and malaria funding requests, together worth just over $400 million. The TB/HIV funding request was for $306.8 million, of which $194.4 million constituted a within-allocation request, with a further $112.4 million as a prioritized above-allocation request (PAAR).
At the annual meeting of the Civil Society Principal Recipients Network (CSPRN), civil society principal recipients (PRs) and the Global Fund examined ways to establish more effective systems and guidelines for dual-track financing and to strengthen the role of civil society within this framework.
E-learning portal for Russian speaking CSOs and communities is launched by a regional platform supported by the Global Fund
An innovative, educational, e-learning portal has been launched to help civil society organizations (CSOs) and communities (i.e. key populations) enhance their knowledge of the responses to HIV and TB. The main focus will be on building the capacity of communities to enable them to become meaningfully involved in the national response to HIV and TB.
In a Window 1 application to the Global Fund, Zanzibar grapples with limited data and tensions affecting key populations
On 20 March 2017, Zanzibar submitted a TB/HIV program continuation request for $6.4 million. Of this amount, just over $0.5 million was a prioritized above allocation request (PAAR), details of which will be presented only during the grant-making stage. The Ministry of Health is the sole principal recipient.
As GFO reported a few weeks ago, Zimbabwe submitted a TB/HIV funding request for $629 million in Window 1 of the current funding cycle. The $629 million request consisted of $432 million that was within Zimbabwe’s allocation, and $197 million for a prioritized above-allocation request (PAAR).
A new database is being developed in Eastern Europe and Central Asia (EECA) containing information on antiretrovirals (ARVs) in use in 15 countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Poland, the Russian Federation, Tajikistan, Ukraine and Uzbekistan.
On 20 March 2017, Zimbabwe submitted a TB/HIV funding request to the Global Fund for $628.9 million. This includes an allocation request for $431.9 million and a prioritized above allocation request (PAAR) of $197 million. A separate funding request for malaria was submitted on the same day for $51.7 million.
In a commentary posted on its website, the Global Network of People Living with HIV (GNP+) has identified three qualities that the next executive director of the Global Fund should exemplify. They are as follows: